novel heterodimers of tetrahydroacridines and tetrahydroquinolinones are disclosed . the heterodimers are capable of acting as both acetylcholinesterase inhibitors and n - methyl - d - aspartate receptor antagonists . the heterodimers may be used to improve cognitive defects via treatment or prevention in both humans and non - humans .